Immunotherapy for Non-Small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome: Erratum

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31823fab4a
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy

The Lancet
Medicine
2019English

Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment

Juntendo Medical Journal
2019English

FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Review of Checkpoint Immunotherapy for the Management of Non-Small Cell Lung Cancer

ImmunoTargets and Therapy
AllergyImmunology
2018English

Acute Interstitial Nephritis in a Patient With Non-Small Cell Lung Cancer Under Immunotherapy With Nivolumab

Case Reports in Nephrology
2019English

Immunotherapy in Extensive Small Cell Lung Cancer

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2019English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

MA10.02 Impact of Antibiotics on Outcome of Metastatic Non Small Cell Lung Cancer Patients Treated With Immunotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy